1Van der Hulst RW, Rauws EA, Koycu B, et al. Prevention of ulcer recurrence after eradication of Helicobacter pylori: a prospective long-term follow-up study. Gastroenterology, 1997, 113: 1082-1086.
2Malfertheiner P, Bayerdorffer E, Diete U, et al. The GU-MACH study: the effect of 1-week omeprazole triple therapy on Helicobacter pylori infection in patients with gastric ulcer. Aliment Pharmacol Ther, 1999, 13: 703-712.
3Bermejo F, Bioxeda D, Gisbert JP, et al. Effects of Helicobacter pylori after eradication on the recurrence of gastric ulcer during a 12-month follow up. Med Clin (Barc), 2000, 115: 201-204.
4International Agency for Research on Cancer. Schistosomes, live flukes and Helicobacter pylori. LARC monographs on the evaluation on carcinogenic risks to humans. Vo161. Lyon: LARC, 1994.
5Wotherspoon AC, Ortiz-Hidgo C, Falzon MR. Helicobacter pylori - associated gastritis and primary B - cdll gastric lymphoma. Lancet, 1991, 338: 1175-1176.
6Eide S, Stolte M, Fisher, et al. Helicobacter pylori gastritis non - Hodgkin's lymphoma. J Ckin Pathol, 1994, 47: 436-439.
7Wotherspoon AC, Dogliani C, Diss TC, et al. Regression of primary low grade B - cell gastric lymphoma of mucosa - associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet, 1993, 342: 4575-4577.
8Perez Aldana L, Kato M, Nakagawa S, et al. The relationship between consumption of antimicrobial agents and the prevalence of primary Helicobacter pylori resistance. Helicobacter, 2002, 7: 306-309.
9Boyanova L, Koumanova R, Gergova G, et al. Prevalence of resistant Helicobacter pylori isolates in Bulgarian children. J Med Microbiol, 2002, 51: 786-790.
10Boyanova L, Mentis A, Gubina M, et al. The status of antimicrobial resistance of Helicobacter pylori in eastern Europe. Clin Microbiol Infect, 2002, 8: 388-396.
